Dermatological Manifestations of COVID-19 in Children

被引:7
作者
Panda, Maitreyee [1 ]
Agarwal, Akash [1 ]
Hassanandani, Trashita [2 ]
机构
[1] IMS & SUM Hosp, Dept Dermatol, K-8 Kalinga Nagar, Bhubaneswar, Orissa, India
[2] Amaltas Inst Med Sci, Dept Dermatol, Dewas, Madhya Pradesh, India
关键词
Chilblains; Erythema multiforme; MIS-C; SARS-CoV-2; MULTISYSTEM INFLAMMATORY SYNDROME; KAWASAKI-DISEASE; URTICARIA; RASH;
D O I
10.1007/s13312-022-2521-6
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Context The clinical picture of pediatric severe acute respiratory syndrome Coronavirus 2 (SARS-CoV-2) infection differs from adults as do the cutaneous manifestations. In this review, we summarize the varied morphological manifestations of SARS-CoV-2 infection in the pediatric population. Evidence acquisition A comprehensive literature search was conducted (23 September, 2021) across multiple databases (PubMed, EMBASE, MEDLINE and Cochrane) with the relevant keywords. An additional filter of age group between 0-18 years was kept in each of the searches. Results Chilblains constitute the most common cutaneous manifestation of pediatric coronavirus disease (COVID-19). Other commonly reported manifestations include maculopapular rash, urticaria, erythema multiforme, and papulovesicular eruptions. Majority of children with these manifestations are asymptomatic, highlighting the need to clinically suspect and appropriately manage such patients. A subset of pediatric patients develop severe multisystem involvement termed as multi-system inflammatory syndrome in children (MIS-C) that has varied mucocutaneous manifestations. Conclusion A wide variety of dermatological manifestation of SARS-CoV-2 infection is reported, and both the pediatrician and dermatologist need to be aware of the same to suspect and diagnose COVID-19 infection in children.
引用
收藏
页码:393 / 399
页数:7
相关论文
共 73 条
[11]   Acute urticaria preceding other COVID-19-associated manifestations-A case report [J].
Chen, Vivien ;
Brehm, Julia Escandon ;
Schmidt, Fernanda Bellodi .
PEDIATRIC DERMATOLOGY, 2021, 38 (02) :455-457
[12]   The underrepresentation of "COVID toes'' in skin of color: An example of racial bias or evidence of a tenuous disease association? [J].
Cline, Abigail ;
Berk-Krauss, Juliana ;
Jacobs, Ashley Keyes ;
Fonseca, Maira ;
Wu, Julia ;
Asrani, Falguni ;
Rizzo, Amilcar ;
Moy, Janet ;
Russo, Marian ;
Glick, Sharon ;
Blasiak, Rachel ;
McLellan, Beth N. ;
Marmon, Shoshana .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2021, 84 (02)
[13]   SARS-CoV-2 endothelial infection causes COVID-19 chilblains: histopathological, immunohistochemical and ultrastructural study of seven paediatric cases [J].
Colmenero, I. ;
Santonja, C. ;
Alonso-Riano, M. ;
Noguera-Morel, L. ;
Hernandez-Martin, A. ;
Andina, D. ;
Wiesner, T. ;
Rodriguez-Peralto, J. L. ;
Requena, L. ;
Torrelo, A. .
BRITISH JOURNAL OF DERMATOLOGY, 2020, 183 (04) :729-737
[14]   The Immunology of Multisystem Inflammatory Syndrome in Children with COVID-19 [J].
Consiglio, Camila Rosat ;
Cotugno, Nicola ;
Sardh, Fabian ;
Pou, Christian ;
Amodio, Donato ;
Rodriguez, Lucie ;
Tan, Ziyang ;
Zicari, Sonia ;
Ruggiero, Alessandra ;
Pascucci, Giuseppe Rubens ;
Santilli, Veronica ;
Campbell, Tessa ;
Bryceson, Yenan ;
Eriksson, Daniel ;
Wang, Jun ;
Marchesi, Alessandra ;
Lakshmikanth, Tadepally ;
Campana, Andrea ;
Villani, Alberto ;
Rossi, Paolo ;
Landegren, Nils ;
Palma, Paolo ;
Brodin, Petter .
CELL, 2020, 183 (04) :968-+
[15]   Are the cutaneous manifestations during or due to SARS-CoV-2 infection/COVID-19 frequent or not? Revision of possible pathophysiologic mechanisms [J].
Criado, Paulo Ricardo ;
Zugaib Abdalla, Beatrice Martinez ;
de Assis, Isabelle Carvalho ;
de Graaff Mello, Cristina van Blarcum ;
Caputo, Gabriela Cacciolari ;
Vieira, Ingrid Campos .
INFLAMMATION RESEARCH, 2020, 69 (08) :745-756
[16]   Dermatological findings inSARS-CoV-2 positive patients: An observational study from North India [J].
Dalal, Ashish ;
Jakhar, Deepak ;
Agarwal, Vishal ;
Beniwal, Ravi .
DERMATOLOGIC THERAPY, 2020, 33 (06)
[17]   Are SARS-CoV-2 IgA antibodies in paediatric patients with chilblain-like lesions indicative of COVID-19 asymptomatic or paucisymptomatic infection? [J].
Diociaiuti, A. ;
Giancristoforo, S. ;
Terreri, S. ;
Corbeddu, M. ;
Concato, C. ;
Atti, M. Ciofi Degli ;
Zambruno, G. ;
Carsetti, R. ;
El Hachem, M. .
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2021, 35 (01) :E10-E13
[18]   Cutaneous Manifestations of COVID-19 in the Inpatient Setting [J].
Do, Mytrang H. ;
Stewart, Claire R. ;
Harp, Joanna .
DERMATOLOGIC CLINICS, 2021, 39 (04) :521-532
[19]   NoSARS-CoV-2 antibody response in 25 patients with pseudo-chilblains [J].
Docampo-Simon, Alexandre ;
Sanchez-Pujol, Maria Jose ;
Gimeno-Gascon, Adelina ;
Palazon-Cabanes, Juan Carlos ;
Juan-Carpena, Gloria ;
Vergara-De Caso, Eduardo ;
Gonzalez-Villanueva, Iris ;
Blanes-Martinez, Mar ;
Betlloch-Mas, Isabel .
DERMATOLOGIC THERAPY, 2020, 33 (06)
[20]   Multisystem Inflammatory Syndrome in Children in New York State [J].
Dufort, Elizabeth M. ;
Koumans, Emilia H. ;
Chow, Eric J. ;
Rosenthal, Elizabeth M. ;
Muse, Alison ;
Rowlands, Jemma ;
Barranco, Meredith A. ;
Maxted, Angela M. ;
Rosenberg, Eli S. ;
Easton, Delia ;
Udo, Tomoko ;
Kumar, Jessica ;
Pulver, Wendy ;
Smith, Lou ;
Hutton, Brad ;
Blog, Debra ;
Zucker, Howard .
NEW ENGLAND JOURNAL OF MEDICINE, 2020, 383 (04) :347-358